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Abstract 
 
Backgtround:  
The absence of any agree-upon tendon health-related domains hampers advances in clinical 
tendinopathy research. This void means that researchers report a very wide range of 
outcome measures inconsistently.  As a result, substantial synthesis/meta-analysis of 
tendon research findings is almost futile despite researchers publishing busily. We aimed to 
determine options for, and then define, core health-related domains for tendinopathy.  
 
Methods: 
We conducted a Delphi study of health care professionals (HCP) and patients in a three-
stage process. In Stage 1, we extracted candidate domains from clinical trial reports and 
developed an online survey. Survey items took the form: ‘The ‘candidate domain’ is 
important enough to be included as a core health-related domain of tendinopathy’;  
response options were: agree, disagree, or unsure. In Stage 2, we administered the online 
survey and reported the findings. Stage 3 consisted of discussions of the findings of the 
survey at the ICON consensus meeting. We set 70% participant agreement as the level 
required for a domain to be considered ‘core’; similarly, 70% agreement was required for a 
domain to be relegated to ‘not core’ (see results below). 
 
Results:  
Twenty-eight HCP (92% of whom had >10 years of tendinopathy experience, 71% consulted 
>10 cases per month) and 32 patients completed the online survey. Fifteen HCP and two 
patients attended the consensus meeting. Of an original set of 24 candidate domains, the 
ICON group deemed nine domains to be core. These were: (i) patient rating of condition, (ii) 
participation in life activities (day to day, work, sport), (iii) pain on activity/loading, (iv) 
function, (v) psychological factors, (vi) physical function capacity, (vii) disability, (viii) quality 
of life, and (ix) pain over a specified time. Two of these (ii, vi) were an amalgamation of five 
candidate domains. We agreed that seven other candidate domains were not core domains: 
range of motion, pain on clinician applied test, clinical examination, palpation, drop out, 
sensory modality pain and pain without other specification. We were undecided on the 
other five candidate domains of physical activity, structure, medication use, adverse effects 
and economic impact. 
 
Conclusion: 
Nine core domains for tendon research should guide reporting of outcomes in clinical trials. 
Further research should determine the best outcome measures for each specific 
tendinopathy (i.e., Core Outcome Sets). 
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Introduction:  
If we review the past two decades of tendinopathy research it appears that progress in 
patient outcomes are on a plateau. (1,2) One factor that may have limited progress is that 
few tendon studies have lent themselves to meta-analysis, (3,4) so that the clinical and 
research community has not agreed on treatment guidelines for the major tendinopathies. 
A specific barrier to meta-analysis of tendon treatment studies is that the original research 
studies report many disparate outcome measures, (3-5) most of which have not been 
validated. (6) A pre-requisite for authors to be able to synthesise and meta-analyse research 
findings from different studies systematically is for numerous studies to contain similar 
outcome measures. It can help to guide a field of clinical research if core outcomes are 
proactively defined and established as a core outcome set. (7)  
 
Before a community of researchers adopt core outcomes widely, the key actors usually first 
agree on core domains. Let us explain the important difference and their logical sequence. 
The ultimate goal, a core outcome set—refers to validated outcome measures that capture 
core health-related domains specific to a condition that have been agreed upon by patients 
and health care professionals (HCP: clinicians and researchers). A very successful example 
comes from The Outcome Measures in Rheumatology (OMERACT) initiative (8) where 
researchers and patients developed a conceptual framework to identify core domains (first) 
before defining a core outcome set. (9) This approach guided our study and this consensus 
statement is limited to the first part—determining core domains. The next phase for tendon 
researchers, developing core outcome measures for specific tendinopathies is planned for 
2020 and beyond. 
 
We aimed to establish (health related) core domains for tendinopathy. We used a three-
stage process: (i) a literature review of clinical trials on tendinopathy, which informed the 
items (candidate domains) to be included in an online survey, (ii) an online survey of HCP 
and patients seeking their opinion on key domains, and finally (iii) a consensus meeting of 
HCP and patients to make decisions on what should be the core domains.  
 
Methods: 
We conducted a consensus process involving HCP and patients, which commenced with 
some of us generating candidate domains from a review of literature (stage 1, June 2018). 
These candidate domains were then considered for their importance as core health-related 
domains in tendinopathy, first by online survey (stage 2, August 2018) and then at an in-
person meeting at the 2018 International Scientific Tendinopathy Symposium (ISTS, 
Groningen, the Netherlands) (stage 3, September 2018). The consensus process described 
here was one of three separate projects discussed at the ISTS consensus meeting; the other 
two dealt with terminology (10) and reporting of participant characteristics. (11) 
 
Participants: 
To achieve a representative group of tendinopathy experts, we selected the HCP cohort 
based on their track record primarily, with consideration for a balance of different 
professional disciplines, sex, likely attendance at the ISTS consensus meeting and 
geographical distribution. The aim was to have an online cohort of approximately 30 
participating HCP, with as many of these to attend the dedicated consensus meeting the day 
before the ISTS symposium. This number of participants is based on previous Delphi studies 
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in similar areas and regarded as an optimal sample size to answer our research question. (12) 
All participants signed an agreement (Appendix A) when they accepted the invitation to 
participate. This stipulated the expectations of participation, as well as the rules for the 
consensus process and authorship of publications.   
 
We aimed to recruit at least 30 patients. For this we used two research databases of 
patients with verified upper and lower limb tendinopathies on clinical or clinical plus 
imaging examination in Brisbane and Melbourne (Australia). The patients on these 
databases were invited to complete the online survey. The head of the local scientific 
committee of ISTS at Groningen (JZ) asked two patients from their clinical research unit to 
participate during the consensus meeting. These patients were proficient in English so they 
could participate in the survey and engage in the English-language meeting.  
 
Ethical approval was gained for the study from the University of Queensland, Australia 
Ethics Committee (Approval #2018001439) and informed consent was obtained from all 
participants.  
 
Procedure Stage 1 - Identifying outcome measures and formulating a candidate domain list: 
The candidate domain list was formed by first undertaking a scoping review of published 
clinical trials in tendinopathy between 2008 and 2018. This generated 122 relevant papers 
and one investigator (BV) extracted all outcome measures reported in those trials. For 
rigour, a research assistant independently extracted outcomes from a random selection of 
20% of those papers, which were then cross-checked. The aim was to generate the broadest 
possible capture of outcomes from which the survey’s candidate domain list was derived.  
 
To move from outcome measures to domains, investigators JZ, SM, ER, AS, BV, and AW then 
constructed a list of potential domains that would make up the items of the survey. The aim 
was not to consolidate domains at this stage, but to ensure that all outcomes were aligned 
to a potential domain. To guide us, we used the International Classification of Functioning 
(ICF) aligned (https://www.who.int/classifications/icf/en/) OMERACT core areas of (a) life 
impact, (b) pathophysiological manifestations, (c) resource use, and (d) death. (9) 
 
Procedure Stage 2 - Online survey relating to candidate domains: 
The candidate domains formed the basis of the online survey (see Appendix B). Each 
candidate domain was included as a separate survey question taking the form ‘Is the 
domain “candidate domain” important enough to be included in a Core Domain Set for 
Tendinopathy?’ and included examples of the outcome measures that were aligned with the 
candidate domain (See Appendix B and Results for alignment).  
 
Survey respondents had three options in response to each question: agree (yes), disagree 
(no), or unsure. The consensus committee (JZ, ER, AS, AW, SM, BV) made an a-priori 
criterion decision that ≥70% of ‘agree’ responses would elevate a candidate domain into the 
‘core’ and ≥70% of disagree responses would relegate the candidate domain to not being 
considered as a core domain. (9,13) The candidate domains that fell between these limits of 
agreement (‘unsure’) were the focus of our discussion session at the ISTS consensus 
meeting.  
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Procedure Stage 3 – ISTS2018 Consensus meeting: 
The results from the online survey were collated (Appendix C) and circulated to all HCP and 
the two patients 10 days prior to the consensus meeting. At the consensus meeting, the 
candidate domains that had been voted as ‘unsure’ (i.e., not already included or excluded 
from the domain set), were discussed in turn. HCP and patients (i.e., the group members) 
then voted as to whether they ‘agreed’ or ‘disagreed’ with each candidate being a core 
domain (forced choice). As with the online survey, a domain had to earn ≥70% of the 
delegates’ votes for either ‘agree’ or ‘disagree’ to be classified into either of those 
categories.  
 
Results: 
Participants--HCP 
Thirty HCP were invited to participate in the overall Delphi process (potentially all 3 stages) 
and 28 responded to the online survey (one did not respond within the timeframe and one 
withdrew after agreeing to participate due to personal reasons, unrelated to the survey). 
Most of the cohort were clinician-researchers with at least 11 years working in the field and 
most (68%) had actually suffered from  tendinopathy personally at some point.  
 
Of these 28 individuals, 15 (54%) attended the ISTS consensus meeting in Groningen on the 
26th September 2018 (Table 1). The meeting group was representative of the online survey 
group in terms of sex, cases of tendinopathy consulted per month, years of clinical 
experience in the field of tendinopathy and having a tendinopathy. There were 
proportionally more physiotherapists than medical professionals at the meeting. There were  
no surgeons at the consensus meeting (Table 1). 
 
Table 1 about here 
 
Participants—patient partners 
All 219 patients registered on the research centres’ databases were sent an email inviting 
them to participate in the survey, with 56 (26%) clicking on the survey link, of which 32 
(57%) then provided consent and completed the survey. A 55-year old woman with Achilles 
tendinopathy not related to a specific sports participation and a 30-year-old man who was a 
former elite middle-distance runner with Achilles tendinopathy, both from Groningen, 
participated during the ISTS consensus meeting. 
 
Domains:  
Stage 1 resulted in 24 candidate domains (Table 2), which formed the basis of the questions 
in the Delphi process. In addition to these 24 candidate domains, we asked survey 
participants to nominate any potential (candidate) tendon health-related domains they 
would remove, add or combine/amalgamate. We collated responses from the survey and 
sent them in a report out to attendees 10 days before the ISTS consensus meeting in 
Groningen (Appendix C). 
 
From the HCP online survey, three candidate domains reached the pre-determined ≥70% 
agree (or disagree) criterion. Pain on Activity/Loading and Disability were voted as core 
domains and Range of Motion voted as not appropriate to be a core domain. 
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From the patient online survey, 11 candidate domains were voted as core domains (see 
Appendix C). No candidate domains met the ≥70% disagree criterion. Pain on 
Activity/Loading was the only candidate domain that was voted into the core domain by 
both patients and HCP. 
 
At the ISTS consensus meeting, attendees moved seven candidate domains from an ‘unsure’ 
status to ≥70% agreement which elevated them to core domain status (Table 2): These 
seven were: Patient Rating of Condition, Participation, Function, Psychological Factors, 
Physical Function Capacity, Quality of Life and Pain over a Specified Time. As explained in 
Table 2, Function is patient rated (e.g., as might be captured on a patient specific function 
scale) whereas Physical Function Capacity is a quantitative measure of function (e.g., 
strength measured on dynamometer). 
 
Attendees at the ISTS consensus meeting amalgamated five separate candidate domains 
from the survey into two core domains. The core domain of Participation was introduced as 
an amalgamation of candidate domains of participation in sport, work and global 
participation. The core domain of Physical Function Capacity was the amalgamation of 
physical function and strength.  
 
Table 2 about here 
 
Seven candidate domains reached the ≥70% voting threshold for agreement that they 
should not serve as core domains (Table 2). Four of these involved clinician examination 
(i.e., pain on clinician examination, examination findings, palpation, range of motion). Pain 
without Further Specification (i.e., context) was deemed to be more precisely covered under 
the two domains, Pain on loading/activity and Pain over specified time. Drop outs and 
sensory modality specific pain were the others. 
 
We were undecided on the other five candidate domains: physical activity, structure, 
medication use, adverse effects and economic impact. 
 
An infographic that conveys the salient design features and results have been developed to 
assist in the implementation of the ICON 9 CORE DOMAINS. 
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Discussion 
 
Brief overview of the findings (at the 70% core/not-core threshold)#: 
Core domains for tendinopathy Not core domains of tendinopathy 
• Patient Rating of Condition • Range of Motion  
• Pain on Activity/Loading  • Pain on Clinician Examination 
• Participation (Daily Activities, Work, Sport)* • Clinical Exam Findings 
• Function • Palpation 
• Psychological Factors • Drop Out 
• Disability  • Sensory Modality Specific Pain 
• Physical Function Capacity (incl. Strength)* • Pain without Further Specification 
• Quality of Life  
• Pain over a specified timeframe  
# see Table 2 for details (and for those candidate domains remaining undecided)  
* candidate domains amalgamated to one domain 
 
What might the nine core domains mean? 
The nine core domains arguably reflect an understanding by HCP and patients of the nature 
of tendinopathy. They encompass both physical (e.g., Pain on Loading, aspects of 
Participation, Function, Physical Function Capacity, Disability), psychosocial (e.g., 
Psychological Factors, aspects of participation and Pain ratings) and overall status/life 
impact (e.g., Patient Rating of Condition and Quality of Life). 
 
There was a 100% agreement that pain could not be measured without reference to context 
(e.g., either to an activity or over a defined period). That is, ratings of pain intensity should 
be made on the basis of some specific activity, loading or time point/timeframe. 
 
Six of the seven core domains decided at the ISTS consensus meeting (2 having reached the 
70% agree threshold prior at the survey stage) had reached the core domain inclusion 
criterion in the online survey of patients. The 6 core domains of Patient Rating of Condition, 
Participation, Function, Physical Function Capacity, Psychological Factors, and Quality of Life 
were agreed upon by both HCP and patients. This adds weight to our belief that these 
domains are meaningful health-related domains for tendinopathy. When HCP and patients 
agree on domains, OMERACT refers to them as ‘inner’ core domains. (9) We recommend that 
outcome measures used in research and clinical practice align with each of these core 
domains, but does not prevent the inclusion of other outcome measures. 
 
What comes next? We will need to define core outcome measures: 
The next stage is to establish the core outcome measures (i.e., core outcome sets) that align 
with each of the domains for the different regional tendinopathies. (9) Many of the domains 
specifically relate to tasks, activities, sports/recreational pursuits and work/occupations that 
load a specific tendon. For example, specific activities, tasks and sport/occupations that are 
associated with Achilles tendinopathy (e.g., distance running) are likely very different to 
those associated with patellar tendinopathy (e.g., jumping sports) or lateral elbow 
tendinopathy (e.g., racquet sports, golf, manual labour). Now that we have determined 9 
core domains for tendinopathy the ICON group resolved to establish anatomic site-specific 
Working Groups to establish core outcome sets for each of the common tendinopathies. An 
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example of a protocol for developing core outcomes for Achilles tendinopathy can be seen 
in the COMET database (http://www.comet-initiative.org/studies/details/1323). 
 
Structure morphology of tendon (as captured by tendon imaging modalities): 
Structure did not reach the 70% threshold to be considered a core domain. The survey 
resulted in 34% and 43% agreement by HCP and patients, respectively. After much 
discussion, there was 69% agreement by participants at the ISTS consensus meeting. The 
main issue for structure not being agreed as a core domain related to the issue of imaging. 
Imaging appearance of tendon has a variable/unclear relationship with symptoms and has 
low diagnostic utility over clinical assessment in many settings. (14) Importantly, imaging is 
not always available so that would limit the feasibility of it being useful to capture a core 
domain. (15) We resolved to form a Working Group to further explore imaging under the 
structure domain and to revisit the topic at the next ISTS meeting. 
 
Alignment with OMERACT core areas: 
Eight of the 9 core domains reflect the life impact core area of OMERACT.(15) Apart from 
Physical Function Capacity, no core domains aligned with the OMERACT core areas of (i) 
pathophysiological manifestations (e.g., Structure 69%, Palpation 13%, Range of Motion 
11%), (ii) death (e.g., Drop out 6% agreement, Adverse effects approx. 60% agreement) or 
(iii) resource use (Economic Impact 40% agreement, Medication use circa 60% agreement).  
 
An interesting outcome of the ICON Core Domain process was the poor representation of 
the OMERACT core area of pathophysiological manifestations. The conventional/prevailing 
view of tendinopathy is that it is a local tissue pathology, which is plausibly/intuitively 
aligned with structure and function domains of the ICF, represented under 
pathophysiological manifestations concept/area in the OMERACT schema. A clear signal of 
the current conceptualisation of tendinopathy being more than a local tendon condition is 
apparent from the 9 core tendinopathy domains not including many of the potential 
candidate domains that belong to the pathophysiological manifestations area in OMERACT. 
 
There was agreement at the meeting that candidate domains such as adverse events and 
medication (other treatments) use would be covered generically for all trials as per 
reporting guidelines (e.g., CONSORT). (16) In summary, the core outcome domains for 
tendinopathy are predominantly of the OMERACT core area of life impact.  
 
Candidate domains about which the group members disagreed were core domains: 
There was a prevailing view at the ISTS consensus meeting that candidate domains that 
were voted not to be core domains ( ≥70% disagree), may still retain use in the clinic. For 
example, Tendon Palpation and Range of Motion, while not core domains, will still be part 
of a clinical examination. Interestingly, the patient’s survey had these candidate domains as 
core (≥70% agree). 
 
Another example, was that the measurement of Sensory Modality-Specific Pain with 
quantitative sensory testing was deemed to be of likely importance in stratification of 
groups of individuals with tendinopathy on the basis of prognosis and possibly predicting 
treatment outcomes, (17) but not as a measure of a health-related nature and thus outcome.  
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Strengths: 
A strength of the process we undertook in deciding these core domains for tendinopathy, 
was that it involved individuals of both sexes, experienced in either treating/researching 
tendinopathy from a range of professions and countries. We also surveyed patients who 
had been diagnosed with tendinopathy by a HCP and involved two local patients in the ISTS 
consensus meeting. That along with many of the HCP having also experienced tendinopathy 
provides a level of assurance that the core domains for tendinopathy are meaningful 
entities representing health-related domains of patients with tendinopathy. The research 
was conducted independent of any funding source (e.g., pharma, health care profession 
associations, sponsors).  
 
Limitations: 
We were only able to have two local patients at the face-to-face ISTS consensus meeting 
and the online survey of patients was only conducted in Australia. This imposes a caveat on 
interpreting the patient survey responses, especially on the candidate domains of Physical 
Activity Levels, Medication Use, Clinical Examination findings and Range of Motion (Table 2). 
Notwithstanding this, the patient views at the consensus meeting appeared to align with 
the online survey.  
 
The discussion on the structure (imaging largely) candidate domain raised the issue that we 
only engaged a single radiologist in the Delphi study. This was slightly offset by the three 
sports medicine physicians and 3 physiotherapists who all had published imaging studies in 
collaboration with radiologists. The meeting decided that further work on imaging 
(structure) was required and should include greater involvement of musculoskeletal 
radiologists who are expert in tendinopathies. 
 
ICON group recommends that: 
(a) Clinical trials should include a measure for each of the 9 core domains at a minimum, so 
that future meta-analyses will likely provide better estimates of treatment effects. 
(b) These core domains should be used alongside clinical trial reporting guidelines (e.g., 
CONSORT) when conducting and reporting clinical trials. 
(c) In future, core outcome sets need to be established for each of the common 
tendinopathies (e.g, Achilles tendon, lateral elbow tendon), using these 9 core domains 
as the guide (and an update reported at the future ISTS). This should identify outcome 
measures that are valid, responsive and feasible as per OMERACT.  
(d) A special interest group including specialist radiologists and clinician scientists who 
regularly use imaging in their practice should discuss imaging further with a view to 
resolving whether tendon structure ought to be included as a core domain. 
(e) The agreed core domains should not prevent the use of other outcomes in trials or 
clinical practice. That is, the core domains represent the minimal reporting requirement. 
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Table 1: Characteristics of the participants completing the online survey and attending the 
consensus meeting. Unless otherwise stated, data is n (%). 
 Survey Meeting 
Characteristic Health Care Professionals  
Patients 
 
Health Care 
Professionals  
Patients 
 
N 28 31 15 2 
Sex: Female 10 (36) 24 (77) 6 (40) 1 (50) 
Age: median (IQR; min-max) 
years 
53 (43-59; 29-
64) 
53 (32-61; 
18-71) 
46 (40-55; 29-
64) 
43 (36-49; 
30-55) 
Role:     
Clinician only 0 1 (3) 0 0 
Researcher/Scientist only 5 (18) 0 3 (20) 0 
Clinician and Researcher 23 (82) 0 12 (80) 0 
Neither Clinician nor 
Researcher/Scientist 0 28 (97) 0 2 (100) 
Tendinopathy cases per month:  NA  NA 
 None 5 (18)  3 (20)  
At least 4 1 (4)  1 (6.7)  
Between 5 and 10 2 (7)  2 (13.3)  
Between 11 and 15 7 (25)  6 (40)  
More than 16 13 (46)  3 (20)  
Years managing tendon 
problems: /27 NA  NA 
None 0  1 (6.7)  
At least 4 0  0  
Between 5 and 10 2 (4)  3 (20)  
Between 11 and 15 6 (22)  3 (20)  
More than 16 19 (70)  8 (53.3)  
Highest academic qualification: /26    
Undergraduate 
Diploma/Certificate 0 
5 (16) 0 0 
Bachelor 0 14 (45) 0 1 (50) 
Master 1 (4) 4 (13) 0 1 (50) 
PhD 23 (88) 5 (16) 13 (86.7) 0 
Clinical Doctorate 2 (8) 0 1 (6.7) 0 
Other 0 3 (10) 1 (6.7)  0 
Health care profession (Some 
cited more than one): 
 ^   
Physiotherapy 13 (40.6)  9 (56)  
Sports & Exercise Medicine 
physician 8 (28.6)  3 (18.8)  
Orthopaedic surgery 4 (12.5)  0 (0)  
Rheumatology 3 (9.4)  1 (6.3)  
Radiology 1 (3.1)  1 (6.3)  
Human movement science 1 (3.1)  1 (6.3)  
Epidemiology 1 (3.1)  1 (6.3)  
Surgery 1 (3.1)  0 (0)  
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Currently have tendon 
problem: 8 (29) 26 (84) 4 (26.7) 2 (100) 
Past history of tendon 
problem: 19 (68) 21 (68) 10 (66.7) 1 (50) 
Country where work:     
Australia 8 (28.6) 31 (100) 5 (33.3)  
United Kingdom 5 (17.9)  1 (6.7)  
The Netherlands 5 (17.9)  4 (26.7) 2 (100) 
Canada 2 (7.1)  1 (6.7)  
USA 2 (7.1)  1 (6.7)  
Denmark 2 (7.1)  1 (6.7)  
Qatar 1 (3.6)  1 (6.7)  
Sweden 1 (3.6)  0  
Hong Kong 1 (3.6)  1 (6.7)  
Norway 1 (3.6)  0  
^ 2 (6.5) physiotherapists, 1 (3.2) nurse midwife, 1 (3.2) social worker, 1 (3.2) athlete 
Abbreviations: N - Number, IQR – Interquartile Range, PhD - Doctor of Philosophy, USA – 
United States of America. 
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Table 2: Domains considered in the meeting in response to the question ‘Is the ‘candidate domain (item)’ important enough to be included in a 
core domain set for tendinopathy?’ Note that the citations placed in the definition column are only examples of some authors reporting of 
indicative outcome measures and they are not to be read as endorsing either the outcomes or their use. 
 
Domain Description/definition (Example Outcome) Consensus 
meeting % 
Survey 
(HCP; P) 
% 
Some typical consensus meeting discussion points. 
Core Domains (Candidate domains (Items) agreed ≥70% agree) 
   
Participant/Patient 
Rating Overall 
Condition 
A single assessment numerical evaluation 
(e.g., Rate your tendon status where 100% is 
no problems and 0% worst case scenario, 
Global Rating of Change (how are you now 
compared to prior treatment) (1-3), Patient 
Acceptable Symptom Status (is your current 
symptom level acceptable?)). 
100 61, 91 Considered to be the most patient-centered 
candidate domain. 
Participation A patient rating of the level of 
participation/engagement across areas of 
their life. (e.g., Ratings of level of sport and 
time to return to sport).(4) 
94 ^ This resulted from the discussion on the three 
candidate domains considered in the survey and at 
the meeting, which were Overall, Sport and Work 
participation. With the exception of the Sport 
participation domain where the patients agreed it 
ought to be a core domain, this candidate domain 
did not reach agreement in the survey. Comments 
in the survey suggested amalgamation, which was 
supported at the meeting.  
Overall (e.g., Time to return to work, level of 
work (strenuousness)). 
^ 25, 65 
 
 
Sport Participation ^ 57, 74 
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Work Participation ^ 46, 65 
 
Pain on 
loading/activity 
Participant/patient reported intensity of 
pain on performing a task/activity that loads 
the tendon. (e.g., VAS or NRS for pain 
intensity when the patient performs a 
tendon-specific pain-provocative task)(5-7). 
* 93, 97 This was strongly agreed at the survey by both 
patients and HCP. Note that there were no 
disagreements. Tendon specific loading tests would 
need to be determined (e.g., pain on gripping an 
object by a patient with lateral elbow 
tendinopathy). 
Function Participant/patient rated level of function 
(and not referring to the intensity of their 
pain). (e.g., Patient Specific Function Scale 
on a VAS or NRS).(2) 
88 68, 87 Discussion centered around possible 
interdependence with Disability, which was 
resolved by considering this candidate domain as 
'how much can the patient do' as opposed to the 
level of disability due to the pain. 
Psychological 
factors 
Psychology (e.g., Pain Self Efficacy, Pain 
Catastrophisation, Kinesiophobia, Anxiety or 
Depression Scales). (2) 
88 36, 77 There was some concern regarding 
interdependence with quality of life, both at the 
meeting and HCP survey. It was agreed that 
psychology was sufficiently important and broader 
than covered in quality of life.  
Physical Function 
Capacity 
Quantitative measures of physical tasks 
performed in clinic (e.g., Number of hops, 
timed stair walk, number of single limb 
squats, including dynamometry (strength) 
and wearable technology). (2,8,9) 
88 57, 68 Some discussion about the differences between 
this and 'Function', but resolved as this is a 
quantitative measure of the physical capacity (e.g., 
number of repetitions of or time to do a task, 
muscle force/torque) and not a patient rating of 
their function (e.g., measured with a patient 
specific function scale).  
Muscle capacity or ‘Strength’ as it was 
considered in the survey and meeting. 
^ 36, 91 Muscle capacity of strength was merged under 
Physical Function Capacity as it was considered a 
physical function measure and there was a high 
patient agreement at survey. It was rejected as a 
separate domain at the meeting (12.5% agree) 
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Disability Composite scores of a mix of patient rated 
pain and disability due to the pain, usually 
relating to tendon-specific activities/tasks. 
(e.g., VISA scales,(2,3,6,7) Patient Rated 
Tennis Elbow Evaluation(10), Disability of 
the Arm, Shoulder and Hand). 
* 86, 69 This was agreed at the survey stage and not 
discussed at the meeting. 
Quality of Life  The general well being of the individual 
(specific QoL questionnaires such as EQ-5D, 
AQoL, SF-36).(2,3,10) 
75 57, 91 There was concern that there is no tendon specific 
QoL measure, but that the overall well being of the 
individual was important to include as a domain.  
Pain over a 
specified time 
Participant reported pain intensity over a 
period of time (morning, night, 24 hours, a 
week) (e.g., VAS, NRS). (10-12) 
75 32, 69 The initial candidate domain was pain over 24 
hours, but also referred to a period of time. After 
discussion it was agreed that it was the 'timeframe' 
being specified that provided more utility (e.g., for 
some tendons morning pain, others night). 
Candidate domains (Items) not reaching ≥70% agree 
   
Physical Activity Overall physical activity levels (e.g., Self 
report of physical activity levels, wearable 
sensor technology). 
69 54, 
81 
Discussion centered around possible interdependence 
and overlap with other domains. Along with this being 
less specific to tendinopathy compared to what some of 
the other domains might be, it did not reach agreement). 
The 69% agreement could be viewed as indicating the 
overlap concern, but that this domain was one requiring 
further consideration. 
Structure Tendon tissue characteristics (e.g., MRI, US, 
biopsy). 
69 43, 
34 
An extended discussion was had on this candidate 
domain, with some of the issues being: relationship to 
symptoms, diagnostic utility, technological, and 
availability of imaging modalities). It was decided to 
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convene a group specific to imaging to deal with this 
candidate domain. 
Medication use Medicines used (e.g., Patient Report or 
Record of type and dose). 
63 57, 
74 
The direct relevance of medication use to tendinopathy 
was a feature of the discussion. It was also considered 
that it would be captured under other reporting 
guidelines for clinical trials. 
Adverse 
effects/events 
Unwanted unintended effects of treatments 
(e.g., Patient report or Medical record). 
56 50, 
58 
Uncertainty about it being specific to tendinopathy, how 
to define it (e.g., pain after exercise), and how to 
measure it. Discussion also considered that adverse 
effects are usually reported under harms as per the 
CONSORT guidelines. 
Economic impact: 
costs 
Financial impost of the condition and its 
management (e.g., Patient report or Medical 
record). 
40 29, 
55 
There was an extended discussion, largely around 
relevancy, societal impact (funding for health care and 
associated research), and how to measure it. 
Not Core Domains (≥70% disagree) 
   
Pain elicited with 
clinician applied 
stress/examination 
Rating of pain when a clinician does 
an examination of the patient. (e.g., 
VAS or NRS for pain intensity). 
21 18, 
61 
Considered more to be for diagnosis and selection into 
studies. 
Clinical examination 
findings 
Clinician report of examination 
findings (e.g., Usually a composite 
score of a number of clinical exam 
tests). 
13 29, 
75 
Considered important in a clinical examination, but the 
composite nature was not meaningful as an outcome. 
Palpation Manual pressure elicited/evoked pain 
over the tendon (e.g., VAS, NRS). 
13 39, 
68 
Considered not to be related to resolution and difficult 
for some tendons (e.g., Shoulder versus Achilles). 
Range of Motion Range of motion (e.g., Goniometer, 
Inclinometer). 
* 11, 
84 
75% disagree HCP survey and not voted at the meeting. 
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Drop out or 
discontinue 
treatment 
Ceasing a treatment (e.g., Patient or 
Clinical record). 
6 46, 
61 
While considered important to be reported in clinical 
trials, it was not a key domain. Re-iteration that 
candidate domains like this should still be reported as 
per other guidelines of reporting. 
Sensory modality 
specific pain 
Pain thresholds/tolerance to sensory 
stimulation (e.g., Quantitative 
Sensory Testing). 
6 11, 
42 
Considered likely useful in sub-grouping studies but not 
as an outcome for trials. 
Pain without 
further specification 
Patient asked about their pain 
without reference to activity or 
timeframe (e.g., VAS, NRS). 
0 25, 
63 
Covered better in pain on loading and over a specified 
timeframe. 
 
* Met the agreed criterion prior to meeting and thus not discussed at the meeting 
^ Amalgamated items (candidate domains) 
 
Abbreviations: HCP – Health Care Professionals, VAS – Visual Analogue Scale, NRS – Numeric Rating Scale, VISA – Victorian Institute of Sports 
Assessment, QoL – Quality of Life, MRI – Magnetic Resonance Imaging, US - Ultrasound, CONSORT - Consolidated Standards of Reporting Trials. 
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